All Stories

  1. The Excess Direct Social Costs of Dementia-Related Neuropsychiatric Symptoms: A Regionwide Cohort Study Beyond Silos

    Article • Value in Health, April 2025, Elsevier

    Javier Mar

  2. The impact of non-pharmaceutical interventions on COVID-19 transmission and its effect on life expectancy in two European regions

    Article • BMC Public Health, March 2025, Springer Science + Business Media

    Javier Mar

  3. Cost-effectiveness of direct oral anticoagulants in non-valvular atrial fibrillation

    Article • Gaceta Sanitaria, February 2025, Elsevier

    Javier Mar

  4. Analysis of sex-specific disease patterns associated with human lifespan

    Article • GeroScience, January 2025, Springer Science + Business Media

    Javier Mar

  5. Electronic health records reveal that COVID-19 impacted health resources and survival of Basque population

    Article • Aging Clinical and Experimental Research, November 2024, Springer Science + Business Media

    Javier Mar

  6. Centenarians of the Basque Country are resilient to cancer

    Article • GeroScience, November 2024, Springer Science + Business Media

    Javier Mar

  7. IPECAD Modeling Workshop 2023 Cross-Comparison Challenge on Cost-Effectiveness Models in Alzheimer’s Disease

    Article • Value in Health, October 2024, Elsevier

    Javier Mar

  8. Effect of the quality of anticoagulation on the risk of stroke, thrombotic events, hemorrhagic events, and death in patients with nonvalvular atrial fibrillation on acenocoumarol in Real-World Data

    Article • F1000Research, September 2024, Faculty of 1000, Ltd.

    Javier Mar

  9. Impact of High Covid-19 Vaccination Rate in an Aging Population: Estimating Averted Hospitalizations and Deaths in the Basque Country, Spain Using Counterfactual Modeling

    Article • Journal of Epidemiology and Global Health, August 2024, Springer Science + Business Media

    Javier Mar

  10. Disparities in antipsychotic prescribing in dementia patients

    Article • Journal of Alzheimer’s Disease, July 2024, IOS Press

    Javier Mar

  11. Socioeconomic and gender inequalities in mental disorders among adolescents and young adults

    Article • Spanish Journal of Psychiatry and Mental Health, April 2024, Elsevier

    Javier Mar

  12. Analysis of response of centenarians of the Basque Country to COVID‐19

    Article • Journal of the American Geriatrics Society, March 2024, Wiley

    Javier Mar

  13. Comorbidity and household income as mediators of gender inequalities in dementia risk: a real-world data population study

    Article • BMC Geriatrics, February 2024, Springer Science + Business Media

    Javier Mar

  14. GOIZ ZAINDU study: a FINGER-like multidomain lifestyle intervention feasibility randomized trial to prevent dementia in Southern Europe

    Article • Alzheimer s Research & Therapy, February 2024, Springer Science + Business Media

    Javier Mar

  15. Using Age-Specific Rates for Parametric Survival Function Estimation in Simulation Models

    Article • Medical Decision Making, February 2024, SAGE Publications

    Dr Fernando Alarid-Escudero, Javier Mar

  16. Sex differences in clinical response to deep brain stimulation in resistant obsessive-compulsive disorder

    Article • Spanish Journal of Psychiatry and Mental Health, February 2024, Elsevier

    Javier Mar

  17. Gaceta Sanitaria en 2023. La función debe continuar. Adiós y gracias

    Article • Gaceta Sanitaria, January 2024, Elsevier

    Javier Mar

  18. Cost-Effectiveness Analysis of Vaccines for COVID-19 According to Sex, Comorbidity and Socioeconomic Status: A Population Study

    Article • PharmacoEconomics, November 2023, Springer Science + Business Media

    Javier Mar

  19. The effect of mixed vaccination rollout strategy: A modelling study

    Article • Infectious Disease Modelling, June 2023, Elsevier

    Javier Mar

  20. Cost-utility analysis of the UPRIGHT intervention promoting resilience in adolescents

    Article • BMC Psychiatry, March 2023, Springer Science + Business Media

    Javier Mar

  21. Do PHI and PHI density improve detection of clinically significant prostate cancer only in the PSA gray zone?

    Article • Clinica Chimica Acta, March 2023, Elsevier

    Javier Mar

  22. Excess healthcare costs of mental disorders in children, adolescents and young adults in the Basque population registry adjusted for socioeconomic status and sex

    Article • Cost Effectiveness and Resource Allocation, March 2023, Springer Science + Business Media

    Javier Mar

  23. Assessment of the Effectiveness, Socio-Economic Impact and Implementation of a Digital Solution for Patients with Advanced Chronic Diseases: The ADLIFE Study Protocol

    Article • International Journal of Environmental Research and Public Health, February 2023, MDPI AG

    Javier Mar

  24. Descriptive and predictive analysis identify centenarians' characteristics from the Basque population

    Article • Frontiers in Public Health, January 2023, Frontiers

    Javier Mar

  25. Incidence of mental disorders in the general population aged 1–30 years disaggregated by gender and socioeconomic status

    Article • Social Psychiatry and Psychiatric Epidemiology, January 2023, Springer Science + Business Media

    Javier Mar

  26. Conflictos armados y crímenes de lesa humanidad. ¿Por qué persisten?

    Article • Gaceta Sanitaria, January 2023, Elsevier

    Javier Mar

  27. Gaceta Sanitaria en 2022. Máximo factor de impacto histórico y adecuación para la publicación continua

    Article • Gaceta Sanitaria, January 2023, Elsevier

    Javier Mar

  28. Coste-efectividad de la vacunación universal infantil frente a la hepatitis A en España: un enfoque dinámico

    Article • Gaceta Sanitaria, January 2023, Elsevier

    Javier Mar

  29. Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain

    Article • Alzheimer s Research & Therapy, November 2022, Springer Science + Business Media

    Javier Mar

  30. Cost-effectiveness and epidemiological impact of gender-neutral HPV vaccination in Spain

    Article • Human Vaccines & Immunotherapeutics, November 2022, Taylor & Francis

    Javier Mar

  31. Cost‐effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross‐comparison challenge

    Article • Alzheimer s & Dementia, October 2022, Wiley

    Javier Mar

  32. Changes in Social and Clinical Determinants of COVID-19 Outcomes Achieved by the Vaccination Program: A Nationwide Cohort Study

    Article • International Journal of Environmental Research and Public Health, October 2022, MDPI AG

    Javier Mar

  33. Long-term comparative effectiveness of deep brain stimulation in severe obsessive-compulsive disorder

    Article • Brain Stimulation, September 2022, Elsevier

    Javier Mar

  34. Modeling the initial phase of COVID-19 epidemic: The role of age and disease severity in the Basque Country, Spain

    Article • PLOS One, July 2022, PLOS

    Javier Mar

  35. An Integrated Care Platform System (C3-Cloud) for Care Planning, Decision Support, and Empowerment of Patients With Multimorbidity: Protocol for a Technology Trial

    Article • JMIR Research Protocols, July 2022, JMIR Publications Inc.

    Javier Mar

  36. Estimation of the epidemiology of dementia and associated neuropsychiatric symptoms by applying machine learning to real-world data

    Article • Revista de Psiquiatría y Salud Mental, July 2022, Elsevier

    Javier Mar

  37. Estimation of the epidemiology of dementia and associated neuropsychiatric symptoms by applying machine learning to real-world data

    Article • Revista de Psiquiatría y Salud Mental (English Edition), July 2022, Elsevier

    Javier Mar

  38. The role of mild and asymptomatic infections on COVID-19 vaccines performance: A modeling study

    Article • Journal of Advanced Research, July 2022, Elsevier

    Javier Mar

  39. Dementia Risk Score for a Population in Southern Europe Calculated Using Competing Risk Models

    Article • Journal of Alzheimer’s Disease, April 2022, IOS Press

    Javier Mar, Javier Mar

  40. Seasonally Forced SIR Systems Applied to Respiratory Infectious Diseases, Bifurcations, and Chaos

    Article • Computational and Mathematical Methods, March 2022, Hindawi Publishing Corporation

    Javier Mar

  41. Gaceta Sanitaria en 2021. Proteger el planeta para proteger la salud

    Article • Gaceta Sanitaria, March 2022, Elsevier

    Javier Mar

  42. Association Between Egg Consumption and Dementia Risk in the EPIC-Spain Dementia Cohort

    Article • Frontiers in Nutrition, February 2022, Frontiers

    Javier Mar

  43. Assessing the Utility and Patient Satisfaction of Virtual Retina Clinics During COVID-19 Pandemic

    Article • Clinical Ophthalmology, February 2022, Taylor & Francis

    Javier Mar

  44. Development and Validation of a Discrete Event Simulation Model to Evaluate the Cardiovascular Impact of Population Policies for Obesity

    Article • Medical Decision Making, October 2021, SAGE Publications

    Javier Mar

  45. Relevance of well-being, resilience, and health-related quality of life to mental health profiles of European adolescents: results from a cross-sectional analysis of the school-based multinational UPRIGHT project

    Article • Social Psychiatry and Psychiatric Epidemiology, August 2021, Springer Science + Business Media

    Javier Mar

  46. Cost-effectiveness of a telemonitoring program (telEPOC program) in frequently admitted chronic obstructive pulmonary disease patients

    Article • Journal of Telemedicine and Telecare, August 2021, SAGE Publications

    Javier Mar

  47. Critical fluctuations in epidemic models explain COVID-19 post-lockdown dynamics

    Article • Scientific Reports, July 2021, Springer Science + Business Media

    Javier Mar

  48. Cost-effectiveness of extending the HPV vaccination to boys: a systematic review

    Article • Journal of Epidemiology & Community Health, June 2021, BMJ

    Javier Mar

  49. Gaceta Sanitaria en 2020. Respuesta editorial a la sindemia e implementación de nuevas normas

    Article • Gaceta Sanitaria, March 2021, Elsevier

    Javier Mar

  50. Mediterranean Diet and Risk of Dementia and Alzheimer’s Disease in the EPIC-Spain Dementia Cohort Study

    Article • Nutrients, February 2021, MDPI AG

    Javier Mar

  51. Cost-effectiveness analysis of text messaging to support health advice for smoking cessation

    Article • Cost Effectiveness and Resource Allocation, February 2021, Springer Science + Business Media

    Javier Mar

  52. Quality of life in patients with nonvalvular atrial fibrillation treated with oral anticoagulants

    Article • Hematology, January 2021, Taylor & Francis

    Javier Mar

  53. Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer’s disease

    Article • Alzheimer s Research & Therapy, December 2020, Springer Science + Business Media

    Javier Mar

  54. Incidence of Dementia and Associated Factors in the EPIC-Spain Dementia Cohort

    Article • Journal of Alzheimer’s Disease, November 2020, IOS Press

    Javier Mar

  55. Modelling COVID 19 in the Basque Country from introduction to control measure response

    Article • Scientific Reports, October 2020, Springer Science + Business Media

    Javier Mar

  56. Validation of Random Forest Machine Learning Models to Predict Dementia-Related Neuropsychiatric Symptoms in Real-World Data

    Article • Journal of Alzheimer’s Disease, September 2020, IOS Press

    Javier Mar, Javier Mar

  57. Plasma lipids are associated with white matter microstructural changes and axonal degeneration

    Article • Brain Imaging and Behavior, August 2020, Springer Science + Business Media

    Javier Mar

  58. Cerebrospinal Fluid 7-Ketocholesterol Level is Associated with Amyloid-β42 and White Matter Microstructure in Cognitively Healthy Adults

    Article • Journal of Alzheimer’s Disease, June 2020, IOS Press

    Pablo Martinez-Lage, Javier Mar

  59. Impact Assessment of an Innovative Integrated Care Model for Older Complex Patients with Multimorbidity: The CareWell Project

    Article • International Journal of Integrated Care, May 2020, Ubiquity Press, Ltd.

    Javier Mar

  60. Impact of an organised population screening programme for colorectal cancer: Measurement after first and second rounds

    Article • Journal of Medical Screening, May 2020, SAGE Publications

    Javier Mar

  61. Dynamic evaluation of the comparative effectiveness of an integrated program for heart failure care

    Article • Journal of Evaluation in Clinical Practice, May 2020, Wiley

    Javier Mar

  62. Changes in lung cancer survival by TNM stage in the Basque country from 2003 to 2014 according to period of diagnosis

    Article • Cancer Epidemiology, April 2020, Elsevier

    Javier Mar

  63. Validation of machine learning models to predict dementia-related neuropsychiatric symptoms in real-world data

    Article • March 2020, Research Square

    Javier Mar

  64. Gaceta Sanitaria en 2019. Trabajando para mejorar la eficiencia en la publicación científica

    Article • Gaceta Sanitaria, March 2020, Elsevier

    Javier Mar

  65. Los retos actuales de la salud mental desde la Salud Pública y la Administración Sanitaria. Informe SESPAS 2020

    Article • Gaceta Sanitaria, January 2020, Elsevier

    Javier Mar

  66. Application of two-part models and Cholesky decomposition to incorporate covariate-adjusted utilities in probabilistic cost-effectiveness models

    Article • Gaceta Sanitaria, January 2020, Elsevier

    Javier Mar

  67. Probabilistic cost-utility analysis and expected value of perfect information for the Oncotype multigenic test: a discrete event simulation model

    Article • Gaceta Sanitaria, January 2020, Elsevier

    Javier Mar

  68. UPRIGHT, a resilience-based intervention to promote mental well-being in schools: study rationale and methodology for a European randomized controlled trial

    Article • BMC Public Health, October 2019, Springer Science + Business Media

    Javier Mar

  69. Factores asociados a la prevalencia de hipovitaminosis D en mujeres embarazadas y sus recién nacidos

    Article • Anales de Pediatría, August 2019, Elsevier

    Javier Mar

  70. Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization

    Article • July 2019, Dove Medical Press

    Javier Mar, Javier Mar

  71. Stage- and age-adjusted cost-effectiveness analysis of laparoscopic surgery in rectal cancer

    Article • Surgical Endoscopy, May 2019, Springer Science + Business Media

    Javier Mar

  72. Gender and socioeconomic inequalities in the implementation of the Basque programme for multimorbid patients

    Article • European Journal of Public Health, May 2019, Oxford University Press (OUP)

    Javier Mar

  73. Inequalities in health-related quality of life according to age, gender, educational level, social class, body mass index and chronic diseases using the Spanish value set for Euroquol 5D-5L questionnaire

    Article • Health and Quality of Life Outcomes, April 2019, Springer Science + Business Media

    Javier Mar

  74. Impacto de la identificación de pacientes en un programa de cuidados paliativos del País Vasco

    Article • Atención Primaria, February 2019, Elsevier

    Javier Mar

  75. Impact of stratification on the effectiveness of a comprehensive patient‐centered strategy for multimorbid patients

    Article • Health Services Research, November 2018, Wiley

    Javier Mar

  76. Observational Study Evaluating the Economic Impact of Breakthrough Pain in Cancer Patients in Clinical Practice in Spain: The IMDI Study

    Article • Pain and Therapy, July 2018, Springer Science + Business Media

    Javier Mar

  77. Cost-effectiveness analysis of laparoscopic versus open surgery in colon cancer

    Article • Surgical Endoscopy, June 2018, Springer Science + Business Media

    NEREA GONZÁLEZ, Javier Mar, Inmaculada Arostegui

  78. Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model

    Article • BMC Cancer, April 2018, Springer Science + Business Media

    Javier Mar

  79. Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals

    Article • ClinicoEconomics and Outcomes Research, March 2018, Dove Medical Press

    ISABEL ALVAREZ LOPEZ, Javier Mar, Javier Mar

  80. Economic Evaluation of an Integrated Health and Social Care Program for Heart Failure Through 2 Different Modeling Techniques

    Article • Health Services Research and Managerial Epidemiology, January 2018, SAGE Publications

    Javier Mar

  81. Economic evaluation of a population strategy for the treatment of chronic hepatitis C with direct-acting antivirals

    Article • Revista Española de Enfermedades Digestivas, January 2018, Sociedad Espanola de Patologia Digestiva (SEPD)

    Javier Mar

  82. Determinants of Informal Care, Burden, and Risk of Burnout in Caregivers of Stroke Survivors

    Article • Stroke, January 2018, Wolters Kluwer Health

    Javier Mar

  83. Survival and clinical events related to end-stage liver disease associated with HCV prior to the era of all oral direct-acting antiviral treatments

    Article • Expert Review of Gastroenterology & Hepatology, October 2017, Taylor & Francis

    Javier Mar

  84. Evaluación de la implementación de un programa integrado de atención a las enfermedades del aparato locomotor

    Article • Reumatología Clínica, July 2017, Elsevier

    Javier Mar

  85. Valoración del coste económico del cáncer colorrectal según estadio tumoral

    Article • Cirugía Española, February 2017, Elsevier

    Javier Mar

  86. Incorporating Budget Impact Analysis in the Implementation of Complex Interventions: A Case of an Integrated Intervention for Multimorbid Patients within the CareWell Study

    Article • Value in Health, January 2017, Elsevier

    Javier Mar

  87. Sofosbuvir plus simeprevir for the treatment of genotype 1 chronic hepatitis C: a review of evidence

    Article • Expert Review of Gastroenterology & Hepatology, September 2016, Taylor & Francis

    Javier Mar

  88. Cost-utility analysis of an integrated care model for multimorbid patients based on a clinical trial

    Article • Gaceta Sanitaria, September 2016, Elsevier

    Javier Mar

  89. Cost-effectiveness analysis of therapeutic options for chronic hepatitis C genotype 3 infected patients

    Article • Expert Review of Gastroenterology & Hepatology, August 2016, Taylor & Francis

    Javier Mar

  90. Economic evaluation of the breast cancer screening programme in the Basque Country: retrospective cost-effectiveness and budget impact analysis

    Article • BMC Cancer, June 2016, Springer Science + Business Media

    Javier Mar

  91. Minimum intravenous thrombolysis utilization rates in acute ischemic stroke to achieve population effects on disability: A discrete-event simulation model

    Article • Journal of the Neurological Sciences, June 2016, Elsevier

    Javier Mar

  92. Economic impact of patients admitted to stroke units in Spain

    Article • The European Journal of Health Economics, April 2016, Springer Science + Business Media

    Javier Mar

  93. Proposal to inform European institutions regarding the regulation of conscientious objection to abortion

    Article • The European Journal of Contraception & Reproductive Health Care, March 2016, Taylor & Francis

    Javier Mar

  94. Análisis coste-efectividad del tratamiento de la hepatitis C crónica con sofosbuvir-simeprevir en pacientes con genotipo 1 y fibrosis avanzada

    Article • Medicina Clínica, January 2016, Elsevier

    Javier Mar

  95. Evaluation of health benefits and harms of the breast cancer screening programme in the Basque Country using discrete event simulation

    Article • BMC Cancer, October 2015, Springer Science + Business Media

    Javier Mar

  96. Projecting Burden of Dementia in Spain, 2010–2050: Impact of Modifying Risk Factors

    Article • Journal of Alzheimer’s Disease, October 2015, SAGE Publications

    Javier Mar

  97. Cost–effectiveness analysis of simeprevir with daclatasvir for non-cirrhotic genotype-1b-naïve patients plus chronic hepatitis C

    Article • Expert Review of Pharmacoeconomics & Outcomes Research, August 2015, Taylor & Francis

    Javier Mar

  98. Outcomes measured by mortality rates, quality of life and degree of autonomy in the first year in stroke units in Spain

    Article • Health and Quality of Life Outcomes, March 2015, Springer Science + Business Media

    Javier Mar

  99. Coste del tratamiento del cáncer de mama por estadío clínico en el País Vasco

    Article • Revista Española de Salud Pública, February 2015, Instituto de Salud Carlos III/BNCS/SciELO Espana

    Javier Mar

  100. Fitting the epidemiology and neuropathology of the early stages of Alzheimer’s disease to prevent dementia

    Article • Alzheimer s Research & Therapy, January 2015, Springer Science + Business Media

    Javier Mar

  101. Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C

    Article • Gut, October 2014, BMJ

    Javier Mar

  102. Cost-Effectiveness of the Use of Biomarkers in Cerebrospinal Fluid for Alzheimer's Disease

    Article • Journal of Alzheimer’s Disease, September 2014, SAGE Publications

    Javier Mar

  103. El coste de la aplicación de la Ley de Dependencia a la enfermedad de Alzheimer

    Article • Gaceta Sanitaria, September 2014, Elsevier

    Javier Mar

  104. Cost–Utility Analysis of Gastric Bypass for Severely Obese Patients in Spain

    Article • Obesity Surgery, June 2014, Springer Science + Business Media

    Javier Mar

  105. Budget Impact Analysis of Switching to Digital Mammography in a Population-Based Breast Cancer Screening Program: A Discrete Event Simulation Model

    Article • PLOS One, May 2014, PLOS

    Javier Mar

  106. Cost-effectiveness of protease inhibitor based regimens for chronic hepatitis C: a systematic review of published literature

    Article • Expert Review of Pharmacoeconomics & Outcomes Research, April 2014, Taylor & Francis

    Javier Mar

  107. An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain

    Article • BMC Cancer, December 2013, Springer Science + Business Media

    Mr Carles Forne, Javier Mar

  108. Mortalidad y costes asociados a la demora del tratamiento quirúrgico por fractura de cadera

    Article • Revista Española de Salud Pública, December 2013, Instituto de Salud Carlos III/BNCS/SciELO Espana

    Javier Mar

  109. Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients

    Article • PharmacoEconomics, September 2013, Springer Science + Business Media

    Javier Mar

  110. Two-year changes in generic and obesity-specific quality of life after gastric bypass

    Article • Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity, May 2013, Springer Science + Business Media

    Javier Mar

  111. Factores que influyen sobre el tiempo hasta la necesidad de intervenir un paciente en la lista de espera para prótesis de rodilla

    Article • Reumatología Clínica, May 2013, Elsevier

    Javier Mar

  112. Incidencia de fracturas de cadera: ¿se está reduciendo?

    Article • Reumatología Clínica, March 2013, Elsevier

    Javier Mar

  113. Modeling using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4

    Article • Value in Health, September 2012, Elsevier

    Javier Mar

  114. Modeling Using Discrete Event Simulation

    Article • Medical Decision Making, September 2012, SAGE Publications

    Javier Mar

  115. Efectividad de una intervención preoperatoria de enfermería sobre el control de la ansiedad de los pacientes quirúrgicos

    Article • Enfermería Clínica, January 2012, Elsevier

    Javier Mar

  116. Calidad de vida y sobrecarga de los cuidadores de pacientes con daño cerebral adquirido

    Article • Revista Española de Geriatría y Gerontología, July 2011, Elsevier

    Javier Mar

  117. Impact of disability on different domains of health-related quality of life in the noninstitutionalized general population

    Article • ClinicoEconomics and Outcomes Research, July 2010, Taylor & Francis

    Javier Mar

  118. Quantifying the effects of normal ageing on white matter structure using unsupervised tract shape modelling

    Article • NeuroImage, May 2010, Elsevier

    Javier Mar

  119. Los modelos de Markov probabilísticos en la evaluación económica de tecnologías sanitarias: una guía práctica

    Article • Gaceta Sanitaria, May 2010, Elsevier

    Javier Mar

  120. Spanish recommendations on economic evaluation of health technologies

    Article • The European Journal of Health Economics, April 2010, Springer Science + Business Media

    Javier Mar

  121. Propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias

    Article • Gaceta Sanitaria, March 2010, Elsevier

    Javier Mar

  122. Budget Impact Analysis of Thrombolysis for Stroke in Spain: A Discrete Event Simulation Model

    Article • Value in Health, January 2010, Elsevier

    Javier Mar

  123. Modelos matemáticos para la evaluación económica: los modelos dinámicos basados en ecuaciones diferenciales

    Article • Gaceta Sanitaria, September 2009, Elsevier

    Javier Mar

  124. Validation of the Spanish Translation of the Questionnaire for the Obesity-Related Problems Scale

    Article • Obesity Surgery, January 2009, Springer Science + Business Media

    Javier Mar

  125. Discrete-Event Simulation Applied to Analysis of Waiting Lists. Evaluation of a Prioritization System for Cataract Surgery

    Article • Value in Health, December 2008, Elsevier

    Javier Mar

  126. Calculation of Prevalence with Markov Models: Budget Impact Analysis of Thrombolysis for Stroke

    Article • Medical Decision Making, March 2008, SAGE Publications

    Javier Mar

  127. Geographical variations in the benefit of applying a prioritization system for cataract surgery in different regions of Spain

    Article • BMC Health Services Research, February 2008, Springer Science + Business Media

    Javier Mar

  128. Calculation of Prevalence Estimates through Differential Equations: Application to Stroke-Related Disability

    Article • Neuroepidemiology, January 2008, Karger Publishers

    Javier Mar

  129. Measuring health-related quality of life in drug clinical trials: is it given due importance?

    Article • Pharmacy World & Science, August 2007, Springer Science + Business Media

    Javier Mar

  130. Análisis coste-efectividad de tipo probabilístico del tratamiento de la apnea del sueño

    Article • Gaceta Sanitaria, January 2006, Elsevier

    Javier Mar

  131. Efecto del tratamiento con presión positiva continua en la vía respiratoria durante la noche en la calidad de vida de los pacientes con apnea del sueño

    Article • Medicina Clínica, November 2005, Elsevier

    Javier Mar

  132. Reliability of portal control procedure in irradiation of breast cancer: A Bayesian analysis

    Article • Radiotherapy and Oncology, April 2005, Elsevier

    Javier Mar

  133. Cost-Effectiveness Analysis of Thrombolytic Treatment for Stroke

    Article • Cerebrovascular Diseases, January 2005, Karger Publishers

    Javier Mar